High frequency of disease progression in pediatric spinal cord low-grade glioma (LGG): management strategies and results from the German LGG study group
Open Access
- 21 December 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in Neuro-Oncology
- Vol. 23 (7) , 1148-1162
Abstract
Knowledge on management of pediatric spinal cord low-grade glioma (LGG) is scarce. We analyzed clinical datasets of 128 pediatric patients with spinal LGG followed within the prospective multicenter trials HIT-LGG 1996 (n = 36), SIOP-LGG 2004 (n = 56), and the subsequent LGG-Interim registry (n = 36). Spinal LGG, predominantly pilocytic astrocytomas (76%), harbored KIAA1549-BRAF fusion in 14/35 patients (40%) and FGFR1-TACC1 fusion in 3/26 patients (12%), as well as BRAFV600E mutation in 2/66 patients (3%). 10-year overall survival (OS) and event-free survival (EFS) was 93% ± 2% and 38% ± 5%, respectively. Disseminated disease (n = 16) was associated with inferior OS and EFS, while age ≥11 years and total resection were favorable factors for EFS. We observed 117 patients following total (n = 24) or subtotal/partial resection (n = 74), biopsy (n = 16), or radiologic diagnosis only (n = 3). Eleven patients were treated first with chemotherapy (n = 9) or irradiation (n = 2). Up to 20.8 years after diagnosis/initial intervention, 73/128 patients experienced one (n = 43) or up to six (n = 30) radiological/clinical disease progressions. Tumor resections were repeated in 36 patients (range, 2-6) and 47 patients required nonsurgical treatment (chemotherapy, n = 20; radiotherapy, n = 10; multiple treatment lines, n = 17). Long-term disease control for a median of 6.5 (range, 0.02-20) years was achieved in 73/77 patients following one (n = 57) or repeated (n = 16) resections, and in 35/47 patients after nonsurgical treatment. The majority of patients experienced disease progression, even after years. Multiple interventions were required for more than a third, yet multimodal treatment enabled long-term disease control. Molecular testing may reveal therapeutic targets.Keywords
Funding Information
- German Cancer Aid (HIT-LGG 1996, 70-2218-Gn1)
- German Children’s Cancer Foundation (SIOP-LGG 2004)
- LGG-registry (2004.5, 2007.10, 2010.08, 2011.16, 2013.19, 2015.19, 2017.13)
- Institute of Neuropathology, University of Bonn (2006.03, 2009.19, 2011.01, 2014.17)
- Clinical Research, University of Münster (2017.13, 2001.05, 2003.09, 2005.07, 2008.07, 2011.02, 2013.21, 2014.15, 2017.07, 2018.02)
This publication has 43 references indexed in Scilit:
- Treatment, prognostic factors, and outcomes in spinal cord astrocytomasNeuro-Oncology, 2013
- Trends in the diagnosis and treatment of pediatric primary spinal cord tumorsJournal of neurosurgery. Pediatrics, 2012
- Long-term follow-up of the multicenter, multidisciplinary treatment study HIT-LGG-1996 for low-grade glioma in children and adolescents of the German Speaking Society of Pediatric Oncology and HematologyNeuro-Oncology, 2012
- Long-Term Outcomes of Patients With Spinal Cord Gliomas Treated by Modern Conformal Radiation TechniquesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- Impact of chemotherapy on disseminated low‐grade glioma in children and adolescents: Report from the HIT‐LGG 1996 trialPediatric Blood & Cancer, 2011
- A multivariate analysis of factors determining tumor progression in childhood low-grade glioma: a population-based cohort study (CCLG CNS9702)Neuro-Oncology, 2010
- Clinical presentation, histology, and treatment in 430 patients with primary tumors of the spinal cord, spinal meninges, or cauda equinaJournal of Neurosurgery: Spine, 2010
- Survival and functional outcome of childhood spinal cord low-grade gliomasJournal of neurosurgery. Pediatrics, 2009
- Low Grade Chiasmatic-Hypothalamic Glioma - Carboplatin and Vincristin Chemotherapy Effectively Defers Radiotherapy within a Comprehensive Treatment StrategyKlinische Padiatrie, 2004
- Effect of spinal irradiation on growth.Archives of Disease in Childhood, 1987